Webinar Securing the Future of mRNA
Join this free webinar
Learn how to build resilient mRNA programs ahead of 2026
Securing the future of mRNA: strategy, science, and resilience in 2026
As momentum in the mRNA field shifts from pandemic response toward chronic disease applications, developers face converging pressures: funding constraints, evolving regulatory expectations, and growing investor and public skepticism. This panel brings together perspectives from established mRNA companies, emerging biotechs, and CDMO leaders to provide a frank, data-informed assessment of where the field stands – and, critically, what organizations can do about it.
Attendees will gain practical frameworks for navigating the current landscape, from de-risking clinical timelines to making informed decisions about when to partner with a CDMO versus building in-house capacity.
Attend this panel to:
- Apply a practical de-risking framework to identify which R&D programs are most vulnerable to funding volatility and regulatory shifts, and take away a diagnostic checklist to assess pipeline resilience
- Gain ready-to-use messaging frameworks for addressing skepticism from institutional investors and the broader public as the mRNA narrative pivots from pandemic response to chronic disease
- Evaluate the strategic case for CDMO partnerships as a tool for externalizing manufacturing risk and reducing overhead during funding dry spells, with guidance on structuring agreements that preserve flexibility
- Take away a structured strategic playbook for aligning scientific, operational, and business priorities in a high-scrutiny environment, informed by the experiences of mRNA leaders and start-ups
